Cambium Bio Limited has released a press release.
Grant of ASX Waiver
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cambium Bio
- Regeneus Market Update
- Regeneus Announces Institutional Placement
- Appendix 4C - Quarterly
- Regeneus partners with Defence to treat combat casualties
- Regeneus to be granted key Progenza patent in Europe
Later from Cambium Bio
- Preliminary Final Report
- Notice of Termination of Kyocera Licence
- Regeneus agrees to settle $2m loan
- Merger with Cambium
- Response to ASX Price Query
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio